Orange Book product · Generic (ANDA)
CETRORELIX ACETATE
CETRORELIX ACETATE
At a glance
Aug 12, 2022
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 12, 2022
3 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
CETRORELIX ACETATE
Strength
EQ 0.25MG BASE/VIAL
Dosage form
POWDER
Route
SUBCUTANEOUS
TE code
AP
Application
ANDA 215737
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CETRORELIX ACETATE
- 2000CETROTIDEBrand (NDA)
NDA 021197 · EMD SERONO INC
- 2026CETRORELIX ACETATEGeneric (ANDA)
ANDA 218740 · EPIC PHARMA LLC
- 2025CETRORELIX ACETATEGeneric (ANDA)
ANDA 218061 · XIROMED
- 2024CETRORELIX ACETATEGeneric (ANDA)
ANDA 218150 · GLAND
- 2024CETRORELIX ACETATEGeneric (ANDA)
ANDA 214540 · LIVZON GRP
- 2024CETRORELIX ACETATEGeneric (ANDA)
ANDA 217776 · QILU
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
